Compare Rivian Automotive, Inc. (RIVN) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rivian Automotive, Inc. vs Tenet Healthcare Corporation — how do they compare? Rivian Automotive, Inc. trades at $14.35 (market cap $20.76B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Rivian Automotive, Inc. and Tenet Healthcare Corporation are close in size by market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rivian Automotive, Inc. for 61 Days and Tenet Healthcare Corporation for 15 Days on average.
| RIVN | THC | |
|---|---|---|
Market Cap | $20.76B | $20.92B |
Volume | 21,976,075 | 455,764 |
Sector | Consumer Cyclical | Health |
52-Week High | $22.45 | $280.77 |
52-Week Low | $12.50 | $161.37 |
Typical Hold Time | 61 Days | 15 Days |
Enterprise Value | $20.81B | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rivian (RIVN) trades at $14.33, down 1.24% on the day, amid bearish technical signals and ongoing financial losses. The company reported record Q3 2026 deliveries of 19,248 vehicles, beating estimates, but maintained its full-year guidance, disappointing investors seeking an upward revision. Revenue growth is improving, with 2025 revenue at $5.39 billion, yet net losses remain substantial at -$3.65 billion, reflecting high costs and scaling challenges in the competitive EV market.
The outlook is mixed: strong delivery growth and analyst buy ratings (48%) suggest potential, but persistent cash burn, negative margins, and technical bearishness pose significant risks. Investors should weigh the company's progress in scaling production and autonomy technology against its hefty losses and competitive pressures in the evolving electric vehicle industry.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
